{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T15:52:33Z","timestamp":1781884353888,"version":"3.54.5"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100012283","name":"Chiayi Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CORPG6K0041-3 and CMRPG6N0151-2"],"award-info":[{"award-number":["CORPG6K0041-3 and CMRPG6N0151-2"]}],"id":[{"id":"10.13039\/501100012283","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["109-2314-B-182A-146 MY2"],"award-info":[{"award-number":["109-2314-B-182A-146 MY2"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["113-2314-B-182A-057"],"award-info":[{"award-number":["113-2314-B-182A-057"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"DOI":"10.1007\/s10822-026-00860-z","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T02:14:51Z","timestamp":1781835291000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of spiropyrrolidinoxindoles as SARS-CoV-2 main protease inhibitor hits from virtual screening"],"prefix":"10.1007","volume":"40","author":[{"given":"Chao-Yu","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Wen","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Yao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Yuan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Hung","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Chih","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Szu","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Fen","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Yuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jrhau","family":"Lung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"issue":"21","key":"860_CR1","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1001\/jama.2023.8656","volume":"329","author":"E Harris","year":"2023","unstructured":"Harris E, WHO Declares End of COVID-19 Global Health Emergency (2023) JAMA 329(21):1817. https:\/\/doi.org\/10.1001\/jama.2023.8656","journal-title":"JAMA"},{"issue":"6","key":"860_CR2","doi-asserted-by":"publisher","first-page":"nwaf138","DOI":"10.1093\/nsr\/nwaf138","volume":"12","author":"W Ma","year":"2025","unstructured":"Ma W, Zhang K, Cao Y, Li M (2025) SARS-CoV-2 keeps evolving, so must our research efforts. Natl Sci Rev 12(6):nwaf138 Epub 20250409. https:\/\/doi.org\/10.1093\/nsr\/nwaf138","journal-title":"Natl Sci Rev"},{"key":"860_CR3","unstructured":"WHO. WHO COVID-19 dashboard: World Health Organization (2025) [cited 2025]. Available from: https:\/\/data.who.int\/dashboards\/covid19\/summary"},{"issue":"2","key":"860_CR4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s44318-023-00019-8","volume":"43","author":"ED Karousis","year":"2024","unstructured":"Karousis ED, Schubert K, Ban N (2024) Coronavirus takeover of host cell translation and intracellular antiviral response: a molecular perspective. EMBO J 43(2):151\u2013167. https:\/\/doi.org\/10.1038\/s44318-023-00019-8","journal-title":"EMBO J"},{"issue":"8","key":"860_CR5","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.3390\/v17081064","volume":"17","author":"VC Soares","year":"2025","unstructured":"Soares VC, Moreira IBG, Dias SSG (2025) SARS-CoV-2 Infection and Antiviral Strategies: Advances and Limitations. Viruses 17(8):1064 PubMed PMID:. https:\/\/doi.org\/10.3390\/v17081064","journal-title":"Viruses"},{"key":"860_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/b978-0-12-821618-7.00111-5","author":"R Mukherjee","year":"2023","unstructured":"Mukherjee R, Dikic I (2023) Proteases of SARS Coronaviruses. Encyclopedia Cell Biology 930\u2013941. . Epub 20221125 https:\/\/doi.org\/10.1016\/b978-0-12-821618-7.00111-5","journal-title":"Encyclopedia Cell Biology"},{"issue":"8","key":"860_CR7","doi-asserted-by":"publisher","first-page":"BSR20231395","DOI":"10.1042\/BSR20231395","volume":"44","author":"K Al Adem","year":"2024","unstructured":"Al Adem K, Ferreira Juliana C, Villanueva Adrian J, Fadl S, El-Sadaany F, Masmoudi I et al (2024) 3-chymotrypsin-like protease in SARS-CoV-2. Biosci Rep 44(8):BSR20231395. https:\/\/doi.org\/10.1042\/BSR20231395","journal-title":"Biosci Rep"},{"issue":"null","key":"860_CR8","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.2147\/DDDT.S359009","volume":"16","author":"J Zhu","year":"2023","unstructured":"Zhu J, Zhang H, Lin Q, Lyu J, Lu L, Chen H et al (2023) Progress on SARS-CoV-2 3CLpro Inhibitors: Inspiration from SARS-CoV 3CLpro Peptidomimetics and Small-Molecule Anti-Inflammatory Compounds. Drug Des Devel Ther 16(null):1067\u20131082. https:\/\/doi.org\/10.2147\/DDDT.S359009","journal-title":"Drug Des Devel Ther"},{"key":"860_CR9","doi-asserted-by":"publisher","unstructured":"Sun Y, Wang L (2024) Development of Anti-HIV Therapeutics: From Conventional Drug Discovery to Cutting-Edge Technology. Pharmaceuticals 17(7):887. https:\/\/doi.org\/10.3390\/ph17070887","DOI":"10.3390\/ph17070887"},{"issue":"10","key":"860_CR10","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1007\/s40262-023-01302-x","volume":"62","author":"M Murray","year":"2023","unstructured":"Murray M (2023) Mechanisms and Clinical Significance of Pharmacokinetic Drug Interactions Mediated by FDA and EMA-approved Hepatitis C Direct-Acting Antiviral Agents. Clin Pharmacokinet 62(10):1365\u20131392. https:\/\/doi.org\/10.1007\/s40262-023-01302-x","journal-title":"Clin Pharmacokinet"},{"key":"860_CR11","doi-asserted-by":"publisher","unstructured":"Galasiti Kankanamalage AC, Kim Y, Damalanka VC, Rathnayake AD, Fehr AR, Mehzabeen N et al (2018) Structure-guided design of potent and permeable inhibitors of MERS coronavirus 3CL protease that utilize a piperidine moiety as a novel design element. Eur J Med Chem. 150:334-46. https:\/\/doi.org\/10.1016\/j.ejmech.2018.03.004","DOI":"10.1016\/j.ejmech.2018.03.004"},{"issue":"1","key":"860_CR12","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1039\/d3md00493g","volume":"15","author":"YL Janin","year":"2024","unstructured":"Janin YL (2024) On the origins of SARS-CoV-2 main protease inhibitors. RSC Med Chem 15(1):81\u2013118 Epub 20231013. https:\/\/doi.org\/10.1039\/d3md00493g","journal-title":"RSC Med Chem"},{"key":"860_CR13","doi-asserted-by":"publisher","first-page":"114367","DOI":"10.1016\/j.biopha.2023.114367","volume":"162","author":"SMR Hashemian","year":"2023","unstructured":"Hashemian SMR, Sheida A, Taghizadieh M, Memar MY, Hamblin MR, Bannazadeh Baghi H et al (2023) Paxlovid (Nirmatrelvir\/Ritonavir): A new approach to Covid-19 therapy? Biomed Pharmacother 162:114367. https:\/\/doi.org\/10.1016\/j.biopha.2023.114367","journal-title":"Biomed Pharmacother"},{"issue":"13","key":"860_CR14","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1056\/NEJMoa2309003","volume":"390","author":"J Hammond","year":"2024","unstructured":"Hammond J, Fountaine Robert J, Yunis C, Fleishaker D, Almas M, Bao W et al (2024) Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19. N Engl J Med 390(13):1186\u20131195. https:\/\/doi.org\/10.1056\/NEJMoa2309003","journal-title":"N Engl J Med"},{"issue":"6","key":"860_CR15","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1002\/cpt.2646","volume":"112","author":"C Marzolini","year":"2022","unstructured":"Marzolini C, Kuritzkes DR, Marra F, Boyle A, Gibbons S, Flexner C et al (2022) Recommendations for the Management of Drug-Drug Interactions Between the COVID-19 Antiviral Nirmatrelvir\/Ritonavir (Paxlovid) and Comedications. Clin Pharmacol Ther 112(6):1191\u20131200 Epub 20220607. https:\/\/doi.org\/10.1002\/cpt.2646","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"860_CR16","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3390\/vaccines10010082","volume":"10","author":"I Hafiz","year":"2022","unstructured":"Hafiz I, Illian DN, Meila O, Utomo AR, Susilowati A, Susetya IE et al (2022) Effectiveness and Efficacy of Vaccine on Mutated SARS-CoV-2 Virus and Post Vaccination Surveillance: A Narrative Review. Vaccines [Internet] 10(1):82 https:\/\/doi.org\/10.3390\/vaccines10010082","journal-title":"Vaccines [Internet]"},{"issue":"7944","key":"860_CR17","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41586-022-05514-2","volume":"613","author":"S Iketani","year":"2023","unstructured":"Iketani S, Mohri H, Culbertson B, Hong SJ, Duan Y, Luck MI et al (2023) Multiple pathways for SARS-CoV-2 resistance to nirmatrelvir. Nature 613(7944):558\u2013564. https:\/\/doi.org\/10.1038\/s41586-022-05514-2","journal-title":"Nature"},{"issue":"3","key":"860_CR18","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s40588-024-00229-6","volume":"11","author":"UM Lopez","year":"2024","unstructured":"Lopez UM, Hasan MM, Havranek B, Islam SM (2024) SARS-CoV-2 Resistance to Small Molecule Inhibitors. Curr Clin Microbiol Rep 11(3):127\u2013139 Epub 20240624. https:\/\/doi.org\/10.1007\/s40588-024-00229-6","journal-title":"Curr Clin Microbiol Rep"},{"issue":"51","key":"860_CR19","doi-asserted-by":"publisher","first-page":"eadd7197","DOI":"10.1126\/sciadv.add7197","volume":"8","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Gammeltoft KA, Ryberg LA, Pham LV, Tj\u00f8rnelund HD, Binderup A et al (2022) Nirmatrelvir-resistant SARS-CoV-2 variants with high fitness in an infectious cell culture system. Sci Adv 8(51):eadd7197 Epub 20221221. https:\/\/doi.org\/10.1126\/sciadv.add7197","journal-title":"Sci Adv"},{"issue":"12","key":"860_CR20","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1002\/ejoc.200300050","volume":"2003","author":"C Marti","year":"2003","unstructured":"Marti C, Carreira Erick M (2003) Construction of Spiro[pyrrolidine-3,3\u2032-oxindoles] \u2013 Recent Applications to the Synthesis of Oxindole Alkaloids. Eur J Org Chem 2003(12):2209\u20132219. https:\/\/doi.org\/10.1002\/ejoc.200300050","journal-title":"Eur J Org Chem"},{"issue":"6","key":"860_CR21","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1007\/s10593-013-1322-1","volume":"49","author":"TL Pavlovskaya","year":"2013","unstructured":"Pavlovskaya TL, Red\u2019kin RG, Yaremenko FG, Shishkina SV, Shishkin OV, Musatov VI et al (2013) Synthesis and chemical properties of new derivatives of 3a\u2019,6a\u2019-dihydro-2\u2019H-spiro- [indole-3,1\u2019-pyrrolo[3,4-c]pyrrole]-2,4\u2019,6\u2018(1H,3\u2019H,5\u2019H)-trione. Chem Heterocycl Compd 49(6):882\u2013896. https:\/\/doi.org\/10.1007\/s10593-013-1322-1","journal-title":"Chem Heterocycl Compd"},{"issue":"2","key":"860_CR22","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1021\/acs.joc.2c02561","volume":"88","author":"M Yasui","year":"2023","unstructured":"Yasui M, Ohbu H, Ishikawa M, Yoshida T, Takeda N, Hirao S et al (2023) Synthesis of Spiro[indole-3,3\u2032-pyrrolidine]-2\u2032-(thi)ones. J Org Chem 88(2):1093\u20131106. https:\/\/doi.org\/10.1021\/acs.joc.2c02561","journal-title":"J Org Chem"},{"key":"860_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-025-02654-4","author":"W Zheng","year":"2025","unstructured":"Zheng W, Wuyun Q, Li Y, Liu Q, Zhou X, Peng C et al (2025) Deep-learning-based single-domain and multidomain protein structure prediction with D-I-TASSER. Nat Biotechnol. https:\/\/doi.org\/10.1038\/s41587-025-02654-4","journal-title":"Nat Biotechnol"},{"issue":"7811","key":"860_CR24","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","volume":"582","author":"Z Jin","year":"2020","unstructured":"Jin Z, Du X, Xu Y, Deng Y, Liu M, Zhao Y et al (2020) Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature 582(7811):289\u2013293. https:\/\/doi.org\/10.1038\/s41586-020-2223-y","journal-title":"Nature"},{"issue":"11","key":"860_CR25","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1021\/acs.jcim.5b00559","volume":"55","author":"T Sterling","year":"2015","unstructured":"Sterling T, Irwin JJ (2015) ZINC 15\u2013Ligand Discovery for Everyone. J Chem Inf Model 55(11):2324\u20132337 Epub 2015\/10\/20. https:\/\/doi.org\/10.1021\/acs.jcim.5b00559","journal-title":"J Chem Inf Model"},{"issue":"16","key":"860_CR26","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS et al (2009) AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem 30(16):2785\u20132791. https:\/\/doi.org\/10.1002\/jcc.21256 PubMed PMID: 19399780; PubMed Central PMCID: PMC2760638","journal-title":"J Comput Chem"},{"key":"860_CR27","doi-asserted-by":"publisher","unstructured":"Li H, Leung K, Wong M (eds) (2012) idock: A multithreaded virtual screening tool for flexible ligand docking. 2012 IEEE Symposium on Computational Intelligence in Bioinformatics and Computational Biology (CIBCB); 9\u201312 May 2012 https:\/\/doi.org\/10.1109\/CIBCB.2012.6217214","DOI":"10.1109\/CIBCB.2012.6217214"},{"issue":"2","key":"860_CR28","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31(2):455\u2013461. https:\/\/doi.org\/10.1002\/jcc.21334 PubMed PMID: 19499576; PubMed Central PMCID: PMC3041641","journal-title":"J Comput Chem"},{"issue":"13","key":"860_CR29","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC et al (2004) UCSF Chimera\u2013a visualization system for exploratory research and analysis. J Comput Chem 25(13):1605\u20131612. 10.1002\/jcc.20084. PubMed PMID: 15264254 https:\/\/doi.org\/10.1002\/jcc.20084","journal-title":"J Comput Chem"},{"issue":"1","key":"860_CR30","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41467-024-55421-5","volume":"16","author":"H Liu","year":"2025","unstructured":"Liu H, Zask A, Forouhar F, Iketani S, Williams A, Vaz DR et al (2025) Development of small molecule non-covalent coronavirus 3CL protease inhibitors from DNA-encoded chemical library screening. Nat Commun 16(1):152 https:\/\/doi.org\/10.1038\/s41467-024-55421-5","journal-title":"Nat Commun"},{"issue":"73","key":"860_CR31","doi-asserted-by":"publisher","first-page":"10866","DOI":"10.1039\/D3CC03285J","volume":"59","author":"G Wang","year":"2023","unstructured":"Wang G, Moitessier N, Mittermaier AK (2023) Computational and biophysical methods for the discovery and optimization of covalent drugs. Chem Commun 59(73):10866\u201310882. https:\/\/doi.org\/10.1039\/D3CC03285J","journal-title":"Chem Commun"},{"issue":"1","key":"860_CR32","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/s41467-023-36304-7","volume":"14","author":"K Obashi","year":"2023","unstructured":"Obashi K, Sochacki KA, Strub MP, Taraska JW (2023) A conformational switch in clathrin light chain regulates lattice structure and endocytosis at the plasma membrane of mammalian cells. Nat Commun 14(1):732 Epub 20230209. https:\/\/doi.org\/10.1038\/s41467-023-36304-7","journal-title":"Nat Commun"},{"issue":"1","key":"860_CR33","doi-asserted-by":"publisher","first-page":"20697","DOI":"10.1038\/s41598-024-71305-6","volume":"14","author":"A Vlachou","year":"2024","unstructured":"Vlachou A, Nchioua R, Regensburger K, Kirchhoff F, Kmiec D (2024) A Gaussia luciferase reporter assay for the evaluation of coronavirus Nsp5\/3CLpro activity. Sci Rep 14(1):20697. https:\/\/doi.org\/10.1038\/s41598-024-71305-6","journal-title":"Sci Rep"},{"key":"860_CR34","doi-asserted-by":"publisher","unstructured":"Schneider CA, Rasband WS, Eliceiri KW (2012) NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9(7):671\u2013675. 10.1038\/nmeth.2089. PubMed PMID: 22930834; PubMed Central PMCID: PMC5554542 https:\/\/doi.org\/10.1038\/nmeth.2089","DOI":"10.1038\/nmeth.2089"},{"issue":"3","key":"860_CR35","doi-asserted-by":"publisher","first-page":"103004","DOI":"10.1016\/j.jbc.2023.103004","volume":"299","author":"GD Noske","year":"2023","unstructured":"Noske GD, de Souza Silva E, de Godoy MO, Dolci I, Fernandes RS, Guido RVC et al (2023) Structural basis of nirmatrelvir and ensitrelvir activity against naturally occurring polymorphisms of the SARS-CoV-2 main protease. J Biol Chem 299(3):103004. https:\/\/doi.org\/10.1016\/j.jbc.2023.103004","journal-title":"J Biol Chem"},{"issue":"9","key":"860_CR36","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.str.2023.06.010","volume":"31","author":"C Lin","year":"2023","unstructured":"Lin C, Jiang H, Li W, Zeng P, Zhou X, Zhang J et al (2023) Structural basis for the inhibition of coronaviral main proteases by ensitrelvir. Structure 31(9):1016\u201324e3. https:\/\/doi.org\/10.1016\/j.str.2023.06.010","journal-title":"Structure"},{"key":"860_CR37","doi-asserted-by":"publisher","unstructured":"Hsu KC, Chen YF, Lin SR, Yang JM (2011) iGEMDOCK: a graphicalenvironment of enhancing GEMDOCK using pharmacological interactions andpost-screening analysis. BMC Bioinformatics 12(Epub 2011\/03\/05 Suppl 1:S33). https:\/\/doi.org\/10.1186\/1471-2105-12-S1-S33","DOI":"10.1186\/1471-2105-12-S1-S33"},{"key":"860_CR38","doi-asserted-by":"publisher","unstructured":"Herdiana I, Kamal MA, Estri MN (2025) A more precise elbow method for optimum K-means clustering. arXiv preprint arXiv :2502. 00851 https:\/\/doi.org\/10.48550\/arXiv.2502.00851","DOI":"10.48550\/arXiv.2502.00851"},{"issue":"1","key":"860_CR39","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1145\/3606274.3606278","volume":"25","author":"E Schubert","year":"2023","unstructured":"Schubert E (2023) Stop using the elbow criterion for k-means and how to choose the number of clusters instead. SIGKDD Explor Newsl 25(1):36\u201342. https:\/\/doi.org\/10.1145\/3606274.3606278","journal-title":"SIGKDD Explor Newsl"},{"key":"860_CR40","doi-asserted-by":"publisher","unstructured":"Candel G, Naccache D (2021) Index -SNE: Tracking Dynamics of High-Dimensional Datasets with Coherent Embeddings. arXiv preprint arXiv:2109 .10538 https:\/\/doi.org\/10.48550\/arXiv.2109.10538","DOI":"10.48550\/arXiv.2109.10538"},{"issue":"1\u20133","key":"860_CR41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/s0169-409x(00)00129-0","volume":"46","author":"CA Lipinski","year":"2001","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46(1\u20133):3\u201326. https:\/\/doi.org\/10.1016\/s0169-409x(00)00129-0 PubMed PMID: 11259830","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"860_CR42","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1021\/ci500588j","volume":"55","author":"T Sander","year":"2015","unstructured":"Sander T, Freyss J, von Korff M, Rufener C (2015) DataWarrior: an open-source program for chemistry aware data visualization and analysis. J Chem Inf Model 55(2):460\u2013473 Epub 2015\/01\/07. https:\/\/doi.org\/10.1021\/ci500588j","journal-title":"J Chem Inf Model"},{"key":"860_CR43","unstructured":"Popovska O The Application Of The Contemporary Computational Graphics In Chemistry"},{"issue":"10","key":"860_CR44","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1021\/ci200227u","volume":"51","author":"RA Laskowski","year":"2011","unstructured":"Laskowski RA, Swindells MB (2011) LigPlot+: Multiple Ligand\u2013Protein Interaction Diagrams for Drug Discovery. J Chem Inf Model 51(10):2778\u20132786. https:\/\/doi.org\/10.1021\/ci200227u","journal-title":"J Chem Inf Model"},{"issue":"5","key":"860_CR45","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1086\/511078","volume":"44","author":"K Halpin","year":"2007","unstructured":"Halpin K, Hyatt AD, Plowright RK, Epstein JH, Daszak P, Field HE et al (2007) Emerging viruses: coming in on a wrinkled wing and a prayer. Clin Infect Dis 44(5):711\u2013717 Epub 2007\/02\/06. https:\/\/doi.org\/10.1086\/511078","journal-title":"Clin Infect Dis"},{"key":"860_CR46","doi-asserted-by":"publisher","first-page":"110445","DOI":"10.1016\/j.virol.2025.110445","volume":"604","author":"M He","year":"2025","unstructured":"He M, He C-Q, Ding N-Z (2025) Human viruses: An ever-increasing list. Virology 604:110445. https:\/\/doi.org\/10.1016\/j.virol.2025.110445","journal-title":"Virology"},{"key":"860_CR47","doi-asserted-by":"publisher","first-page":"100986","DOI":"10.1016\/j.drup.2023.100986","volume":"70","author":"A Vitiello","year":"2023","unstructured":"Vitiello A, Zovi A, Rezza G (2023) New emerging SARS-CoV-2 variants and antiviral agents. Drug Resist Updates 70:100986. https:\/\/doi.org\/10.1016\/j.drup.2023.100986","journal-title":"Drug Resist Updates"},{"issue":"1","key":"860_CR48","doi-asserted-by":"publisher","first-page":"e1004493","DOI":"10.1371\/journal.pmed.1004493","volume":"22","author":"A Bhatia","year":"2025","unstructured":"Bhatia A, Preiss AJ, Xiao X, Brannock MD, Alexander GC, Chew RF et al (2025) Effect of nirmatrelvir\/ritonavir (Paxlovid) on hospitalization among adults with COVID-19: An electronic health record-based target trial emulation from N3C. PLoS Med 22(1):e1004493 Epub 20250117. https:\/\/doi.org\/10.1371\/journal.pmed.1004493","journal-title":"PLoS Med"},{"issue":"6","key":"860_CR49","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1093\/cid\/ciaf521","volume":"81","author":"C Calabrese","year":"2026","unstructured":"Calabrese C, Wang Y, Duggal A, Huang S, Fan Y, Kethireddy S et al (2026) Effectiveness of Nirmatrelvir\/Ritonavir or Molnupiravir Use in Immunocompromised Patients on B-Cell-Depleting Therapy With COVID-19: A Target Trial Emulation Study. Clin Infect Dis 81(6):1065\u20131073. https:\/\/doi.org\/10.1093\/cid\/ciaf521","journal-title":"Clin Infect Dis"},{"key":"860_CR50","doi-asserted-by":"publisher","unstructured":"Dzobo K (2022) The Role of Natural Products as Sources of Therapeutic Agents for Innovative Drug Discovery. Comprehensive Pharmacology. :408\u2009\u2013\u200922. Epub 20220609. https:\/\/doi.org\/10.1016\/b978-0-12-820472-6.00041-4. PubMed Central PMCID: PMC8016209","DOI":"10.1016\/b978-0-12-820472-6.00041-4"},{"key":"860_CR51","doi-asserted-by":"publisher","unstructured":"Daley SK, Cordell GA (2021) Alkaloids in Contemporary Drug Discovery to Meet Global Disease Needs. Molecules.26(13):3800. https:\/\/doi.org\/10.3390\/molecules26133800","DOI":"10.3390\/molecules26133800"},{"issue":"1","key":"860_CR52","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1038\/s41467-019-10415-6","volume":"10","author":"WS Kim","year":"2019","unstructured":"Kim WS, Shalit ZA, Nguyen SM, Schoepke E, Eastman A, Burris TP et al (2019) A synthesis strategy for tetracyclic terpenoids leads to agonists of ER\u03b2. Nat Commun 10(1):2448. https:\/\/doi.org\/10.1038\/s41467-019-10415-6","journal-title":"Nat Commun"},{"issue":"9","key":"860_CR53","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.3390\/biom13091339","volume":"13","author":"A Citarella","year":"2023","unstructured":"Citarella A, Dimasi A, Moi D, Passarella D, Scala A, Piperno A et al (2023) Recent Advances in SARS-CoV-2 Main Protease Inhibitors: From Nirmatrelvir to Future Perspectives. Biomolecules [Internet] 13(9):1339 https:\/\/doi.org\/10.3390\/biom13091339","journal-title":"Biomolecules [Internet]"},{"issue":"19","key":"860_CR54","doi-asserted-by":"publisher","first-page":"12500","DOI":"10.1021\/acs.jmedchem.2c01005","volume":"65","author":"G La Monica","year":"2022","unstructured":"La Monica G, Bono A, Lauria A, Martorana A (2022) Targeting SARS-CoV-2 Main Protease for Treatment of COVID-19: Covalent Inhibitors Structure\u2013Activity Relationship Insights and Evolution Perspectives. J Med Chem 65(19):12500\u201312534. https:\/\/doi.org\/10.1021\/acs.jmedchem.2c01005","journal-title":"J Med Chem"},{"issue":"17","key":"860_CR55","doi-asserted-by":"publisher","first-page":"4159","DOI":"10.1021\/jm049582b","volume":"47","author":"BE Haug","year":"2004","unstructured":"Haug BE, Stensen W, Stiberg T, Svendsen JS (2004) Bulky Nonproteinogenic Amino Acids Permit the Design of Very Small and Effective Cationic Antibacterial Peptides. J Med Chem 47(17):4159\u20134162. https:\/\/doi.org\/10.1021\/jm049582b","journal-title":"J Med Chem"},{"issue":"7","key":"860_CR56","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1021\/acs.bioconjchem.2c00144","volume":"33","author":"NL Kj\u00e6rsgaard","year":"2022","unstructured":"Kj\u00e6rsgaard NL, Hansen RA, Gothelf KV (2022) Preparation of Maleimide-Modified Oligonucleotides from the Corresponding Amines Using N\u2013Methoxycarbonylmaleimide. Bioconjug Chem 33(7):1254\u20131260. https:\/\/doi.org\/10.1021\/acs.bioconjchem.2c00144","journal-title":"Bioconjug Chem"},{"issue":"1","key":"860_CR57","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1021\/jo00915a004","volume":"39","author":"AL Schwartz","year":"1974","unstructured":"Schwartz AL, Lerner LM (1974) Preparation of N-substituted maleimides by direct coupling of alkyl or aralkyl halides with heavy metal salts of maleimide. J Org Chem 39(1):21\u201323. https:\/\/doi.org\/10.1021\/jo00915a004","journal-title":"J Org Chem"},{"key":"860_CR58","doi-asserted-by":"publisher","unstructured":"Ruslan Gr. Redkin EIS, Leonid A. Shemchuk, Valentin P. Chernykh. Synthesis and antimicrobial activity of Bis-Derivatives of 3a\u2032, 6a\u2032Dihydro-2\u2019H-Spiro[Indole-3,1\u2019-Pyrrolo[3,4-c]Pyrrole]-2,4\u2019,6\u2018(1H,3\u2019H, 5\u2019H)-Trione: Issue: 6; 2017. 069\u201378 p. https:\/\/doi.org\/10.7324\/JAPS.2017.70610","DOI":"10.7324\/JAPS.2017.70610"},{"issue":"18","key":"860_CR59","doi-asserted-by":"publisher","first-page":"6488","DOI":"10.3390\/molecules28186488","volume":"28","author":"H Zhao","year":"2023","unstructured":"Zhao H, Zhao Y (2023) Engaging Isatins and Amino Acids in Multicomponent One-Pot 1,3-Dipolar Cycloaddition Reactions\u2014Easy Access to Structural Diversity. Molecules [Internet] 28(18):6488 p.] https:\/\/doi.org\/10.3390\/molecules28186488","journal-title":"Molecules [Internet]"},{"issue":"2","key":"860_CR60","doi-asserted-by":"publisher","first-page":"274","DOI":"10.3390\/ph18020274","volume":"18","author":"AS Girgis","year":"2025","unstructured":"Girgis AS, Zhao Y, Nkosi A, Ismail NSM, Bekheit MS, Aboshouk DR et al (2025) The Therapeutic Potential of Spirooxindoles in Cancer: A Focus on p53\u2013MDM2 Modulation. Pharmaceuticals [Internet] 18(2):274 https:\/\/doi.org\/10.3390\/ph18020274","journal-title":"Pharmaceuticals [Internet]"},{"issue":"28","key":"860_CR61","doi-asserted-by":"publisher","first-page":"22336","DOI":"10.1039\/D5RA03404C","volume":"15","author":"MS Nafie","year":"2025","unstructured":"Nafie MS, Shawish I, Fahmy SA, Diab MK, Abdelfattah MM, Hassen BM et al (2025) Recent advances in the halogenated spirooxindoles as novel anticancer scaffolds: chemistry and bioactivity approach. RSC Adv 15(28):22336\u201322375. https:\/\/doi.org\/10.1039\/D5RA03404C","journal-title":"RSC Adv"},{"issue":"19","key":"860_CR62","doi-asserted-by":"publisher","first-page":"11861","DOI":"10.3390\/ijms231911861","volume":"23","author":"A Barakat","year":"2022","unstructured":"Barakat A, Mostafa A, Ali M, Al-Majid AM, Domingo LR, Kutkat O et al (2022) Design, synthesis and in vitro evaluation of spirooxindole-based phenylsulfonyl moiety as a candidate anti-SAR-CoV-2 and MERS-CoV-2 with the Implementation of combination studies. Int J Mol Sci 23(19):11861 https:\/\/doi.org\/10.3390\/ijms231911861","journal-title":"Int J Mol Sci"},{"issue":"1","key":"860_CR63","doi-asserted-by":"publisher","first-page":"13880","DOI":"10.1038\/s41598-022-17883-9","volume":"12","author":"NG Fawazy","year":"2022","unstructured":"Fawazy NG, Panda SS, Mostafa A, Kariuki BM, Bekheit MS, Moatasim Y et al (2022) Development of spiro-3-indolin-2-one containing compounds of antiproliferative and anti-SARS-CoV-2 properties. Sci Rep 12(1):13880 https:\/\/doi.org\/10.1038\/s41598-022-17883-9","journal-title":"Sci Rep"},{"issue":"8","key":"860_CR64","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s44222-023-00063-3","volume":"1","author":"A Loewa","year":"2023","unstructured":"Loewa A, Feng JJ, Hedtrich S (2023) Human disease models in drug development. Nat Reviews Bioeng 1(8):545\u2013559. https:\/\/doi.org\/10.1038\/s44222-023-00063-3","journal-title":"Nat Reviews Bioeng"},{"key":"860_CR65","doi-asserted-by":"publisher","first-page":"1550158","DOI":"10.3389\/fphar.2025.1550158","volume":"16","author":"Q An","year":"2025","unstructured":"An Q, Huang L, Wang C, Wang D, Tu Y (2025) New strategies to enhance the efficiency and precision of drug discovery. Front Pharmacol 16:1550158 Epub 20250211. doi: 10.3389\/fphar.2025.1550158. PubMed PMID: 40008135; PubMed Central PMCID: PMC11850385 https:\/\/doi.org\/10.3389\/fphar.2025.1550158","journal-title":"Front Pharmacol"},{"key":"860_CR66","doi-asserted-by":"publisher","first-page":"102829","DOI":"10.1016\/j.sbi.2024.102829","volume":"87","author":"J Carlsson","year":"2024","unstructured":"Carlsson J, Luttens A (2024) Structure-based virtual screening of vast chemical space as a starting point for drug discovery. Curr Opin Struct Biol 87:102829. https:\/\/doi.org\/10.1016\/j.sbi.2024.102829","journal-title":"Curr Opin Struct Biol"},{"issue":"16","key":"860_CR67","doi-asserted-by":"publisher","first-page":"e202200278","DOI":"10.1002\/cmdc.202200278","volume":"17","author":"JP Cer\u00f3n-Carrasco","year":"2022","unstructured":"Cer\u00f3n-Carrasco JP (2022) When Virtual Screening Yields Inactive Drugs: Dealing with False Theoretical Friends. ChemMedChem 17(16):e202200278. https:\/\/doi.org\/10.1002\/cmdc.202200278","journal-title":"ChemMedChem"},{"issue":"6","key":"860_CR68","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1080\/17460441.2022.2085685","volume":"17","author":"D Bajusz","year":"2022","unstructured":"Bajusz D, Keser\u0171 GM (2022) Maximizing the integration of virtual and experimental screening in hit discovery. Expert Opin Drug Discov 17(6):629\u2013640. https:\/\/doi.org\/10.1080\/17460441.2022.2085685","journal-title":"Expert Opin Drug Discov"},{"issue":"24","key":"860_CR69","doi-asserted-by":"publisher","first-page":"9041","DOI":"10.3390\/molecules27249041","volume":"27","author":"L Ivanova","year":"2022","unstructured":"Ivanova L, Karelson M (2022) The Impact of Software Used and the Type of Target Protein on Molecular Docking Accuracy. Molecules [Internet] 27(24):9041 p.] https:\/\/doi.org\/10.3390\/molecules27249041","journal-title":"Molecules [Internet]"},{"issue":"49","key":"860_CR70","doi-asserted-by":"publisher","first-page":"12027","DOI":"10.1021\/acs.jpcb.4c06614","volume":"128","author":"B Roux","year":"2024","unstructured":"Roux B, Chipot C (2024) Editorial Guidelines for Computational Studies of Ligand Binding Using MM\/PBSA and MM\/GBSA Approximations Wisely. J Phys Chem B 128(49):12027\u201312029. https:\/\/doi.org\/10.1021\/acs.jpcb.4c06614","journal-title":"J Phys Chem B"},{"issue":"4","key":"860_CR71","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1021\/acs.jcim.2c01253","volume":"63","author":"BI Tingle","year":"2023","unstructured":"Tingle BI, Tang KG, Castanon M, Gutierrez JJ, Khurelbaatar M, Dandarchuluun C et al (2023) ZINC-22A Free Multi-Billion-Scale Database of Tangible Compounds for Ligand Discovery. J Chem Inf Model 63(4):1166\u20131176. https:\/\/doi.org\/10.1021\/acs.jcim.2c01253","journal-title":"J Chem Inf Model"},{"issue":"10","key":"860_CR72","doi-asserted-by":"publisher","first-page":"3784","DOI":"10.1073\/pnas.1117768109","volume":"109","author":"M Gao","year":"2012","unstructured":"Gao M, Skolnick J (2012) The distribution of ligand-binding pockets around protein-protein interfaces suggests a general mechanism for pocket formation. Proc Natl Acad Sci U S A 109(10):3784\u20133789 Epub 20120221. https:\/\/doi.org\/10.1073\/pnas.1117768109","journal-title":"Proc Natl Acad Sci U S A"},{"key":"860_CR73","doi-asserted-by":"publisher","DOI":"10.1101\/2025.02.04.636483","author":"H Zillmer","year":"2025","unstructured":"Zillmer H, Walther D Towards a comprehensive view of the pocketome universe \u2013 biological implications and algorithmic challenges. bioRxiv. https:\/\/doi.org\/10.1101\/2025.02.04.636483","journal-title":"bioRxiv"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-026-00860-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-026-00860-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-026-00860-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T15:02:28Z","timestamp":1781881348000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-026-00860-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["860"],"URL":"https:\/\/doi.org\/10.1007\/s10822-026-00860-z","relation":{},"ISSN":["1573-4951"],"issn-type":[{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"assertion":[{"value":"17 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"152"}}